- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01516489
Improving Fecal Occult Blood Test Completion Rates Among Veterans
23. oktober 2015 opdateret af: Steven C. Marcus, PhD, Corporal Michael J. Crescenz VA Medical Center
This is a 4-arm cluster randomized controlled trial to evaluate whether patient financial incentives directly integrated into primary care can improve fecal occult blood test (FOBT) completion rates.
We will recruit primary care patients at the Philadelphia Veterans Affairs Medical Center (PVAMC) in 2 stages.
In stage 1, we hypothesize that, compared to usual care, $5, $10, $20 incentives will each lead to a statistically significant increase in the rate of FOBT completion.
We also hypothesize that there will be a direct dose-response relationship between the incentive amount and rates of FOBT completion.
In stage 2, we hypothesize that a lottery-based incentive and a raffle-based incentive will both lead to a statistically significant increase in the rate of FOBT completion compared to a fixed payment incentive with an equivalent dollar per patient value.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
1549
Fase
- Fase 2
- Fase 1
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forenede Stater, 19104
- Philadelphia Veterans Affairs Medical Center
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Han
Beskrivelse
Inclusion Criteria:
- PVAMC outpatients who are prescribed an FOBT kit in Module B or C during the study period.
Exclusion Criteria:
- None. All PVAMC outpatients who are prescribed an FOBT kit in Module B or C during the study period will be eligible.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Stage 1 Control Group
In the FOBT kit, individuals will receive a card that asks them to complete and return their FOBT kit within 30 days.
|
|
|
Eksperimentel: $5 Incentive
In the FOBT kit, individuals will receive a card that states that if they complete and return their FOBT kit within 30 days, they will be mailed a voucher that can be exchanged for $5 at PVAMC.
|
Patients who are prescribed an FOBT kit in one of the PVAMC Primary Care clinics (i.e., Module B or C) will be randomly assigned by day to one of 4 study arms.
All FOBT kits will include a card with a description of the arm that the patient has been randomized to.
|
|
Eksperimentel: $10 Incentive
In the FOBT kit, individuals will receive a card that states that if they complete and return their FOBT kit within 30 days, they will be mailed a voucher that can be exchanged for $10 at PVAMC.
|
Patients who are prescribed an FOBT kit in one of the PVAMC Primary Care clinics (i.e., Module B or C) will be randomly assigned by day to one of 4 study arms.
All FOBT kits will include a card with a description of the arm that the patient has been randomized to.
|
|
Eksperimentel: $20 Incentive
In the FOBT kit, individuals will receive a card that states that if they complete and return their FOBT kit within 30 days, they will be mailed a voucher that can be exchanged for $20 at PVAMC.
|
Patients who are prescribed an FOBT kit in one of the PVAMC Primary Care clinics (i.e., Module B or C) will be randomly assigned by day to one of 4 study arms.
All FOBT kits will include a card with a description of the arm that the patient has been randomized to.
|
|
Eksperimentel: $5 Voucher-Based Incentive
In the FOBT kit, individuals will receive a card that states that if they complete and return their FOBT kit within 30 days, they will be mailed a voucher that can be exchanged for $5 at PVAMC.
|
Patients who are prescribed an FOBT kit in one of the PVAMC Primary Care clinics (i.e., Module B or C) will be randomly assigned by day to one of 4 study arms.
All FOBT kits will include a card with a description of the arm that the patient has been randomized to.
The exact dollar amounts for the Voucher-Based Incentive, Lottery-Based Incentive, and Raffle-Based Incentive arms will be based on the results of Stage 1.
|
|
Eksperimentel: $50 Lottery-Based Incentive
In the FOBT kit, individuals will receive a card that states that if they complete and return their FOBT kit within 30 days, they will have a 1 in 10 chance of being mailed a voucher that can be exchanged for $50 at PVAMC.
|
Patients who are prescribed an FOBT kit in one of the PVAMC Primary Care clinics (i.e., Module B or C) will be randomly assigned by day to one of 4 study arms.
All FOBT kits will include a card with a description of the arm that the patient has been randomized to.
The exact dollar amounts for the Voucher-Based Incentive, Lottery-Based Incentive, and Raffle-Based Incentive arms will be based on the results of Stage 1.
|
|
Eksperimentel: $500 Raffle-Based Incentive
In the FOBT kit, individuals will receive a card that states that if they complete and return their FOBT kit within 30 days, they will be entered into a raffle in which 1 randomly chosen patient (out of about 100 patients) will be mailed a check in the amount of $500.
|
Patients who are prescribed an FOBT kit in one of the PVAMC Primary Care clinics (i.e., Module B or C) will be randomly assigned by day to one of 4 study arms.
All FOBT kits will include a card with a description of the arm that the patient has been randomized to.
The exact dollar amounts for the Voucher-Based Incentive, Lottery-Based Incentive, and Raffle-Based Incentive arms will be based on the results of Stage 1.
|
|
Ingen indgriben: Stage 2 Control Group
In the FOBT kit, individuals will receive a card that asks them to complete and return their FOBT kit within 30 days.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
FOBT completion and return
Tidsramme: 30 days
|
30 days
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
FOBT completion rate among previously non-adherent patients and FOBT kit return time by arm
Tidsramme: 30 days
|
There are 2 secondary outcomes.
First, we will compare time to FOBT kit return by arm.
Second, we will compare 30 day FOBT completion rates among previously non-adherent patients (i.e., individuals who had failed to complete a prescribed FOBT kit in the year prior to the start of the study) by arm.
|
30 days
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Jeffrey T Kullgren, MD, MS, MPH, Corporal Michael J. Crescenz VA Medical Center
- Studieleder: Steven C Marcus, PhD, Corporal Michael J. Crescenz VA Medical Center
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. februar 2012
Primær færdiggørelse (Faktiske)
1. oktober 2013
Studieafslutning (Faktiske)
1. juni 2015
Datoer for studieregistrering
Først indsendt
19. januar 2012
Først indsendt, der opfyldte QC-kriterier
19. januar 2012
Først opslået (Skøn)
25. januar 2012
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
26. oktober 2015
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
23. oktober 2015
Sidst verificeret
1. oktober 2015
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 01334
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kolorektal cancer
-
University of ArkansasRekrutteringColorectal cancer og inflammatorisk tarmsygdomForenede Stater
-
University Health Network, TorontoAstraZenecaAktiv, ikke rekrutterendeAdenocarcinom i bugspytkirtlen | Leiomyosarkom | Mismatch Reparation Proficient Colorectal CancerCanada
-
Stingray TherapeuticsRekrutteringRefractory Metastatic Microsatellite Stabil Colorectal Cancer (MSS-CRC)Forenede Stater
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaIkke rekrutterer endnuKolorektal kirurgi | Robotkirurgi | Colorectal cancer og inflammatorisk tarmsygdom
-
Tianjin Medical University Cancer Institute and...RekrutteringMSI-H Advanced Colorectal CancerKina
-
Bristol-Myers SquibbAfsluttetMikrosatellit stabil kolorektal cancer | Mismatch Reparation Proficient Colorectal Cancer | Mikrosatellit ustabil kolorektal cancer | Mismatch Reparation Manglende tyktarmskræftForenede Stater, Australien, Belgien, Canada, Irland, Italien, Spanien, Frankrig
-
Syndax PharmaceuticalsMerck Sharp & Dohme LLCAfsluttetMelanom | Ikke-småcellet lungekræft | Mismatch Reparation-Proficient Colorectal CancerForenede Stater
Kliniske forsøg med Stage 1
-
Assistance Publique - Hôpitaux de ParisCentre Hospitalier Sainte Anne, Paris; Département d'Epidémiologie Clinique... og andre samarbejdspartnereAfsluttet
-
Imperial College LondonGlaxoSmithKlineAfsluttet
-
Orasis Pharmaceuticals Ltd.Afsluttet
-
University of ThessalyAfsluttet
-
The University of Texas Health Science Center,...National Heart, Lung, and Blood Institute (NHLBI); United States Department... og andre samarbejdspartnereAfsluttetTraumaForenede Stater, Canada
-
Queen Margaret UniversityNHS LothianAfsluttet
-
Chulalongkorn UniversityAfsluttetAllergisk rhinitisThailand
-
University of Sao Paulo General HospitalAfsluttetOveraktiv blæresyndromBrasilien
-
University of Sao Paulo General HospitalAfsluttet
-
Montreal Heart InstituteInstitut de Recherches Cliniques de Montreal; Royal Victoria Hospital,... og andre samarbejdspartnereAfsluttetHypertriglyceridæmiCanada